BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20158204)

  • 1. Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.
    Carroll FI; Blough BE; Mascarella SW; Navarro HA; Eaton JB; Lukas RJ; Damaj MI
    J Med Chem; 2010 Mar; 53(5):2204-14. PubMed ID: 20158204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.
    Lukas RJ; Muresan AZ; Damaj MI; Blough BE; Huang X; Navarro HA; Mascarella SW; Eaton JB; Marxer-Miller SK; Carroll FI
    J Med Chem; 2010 Jun; 53(12):4731-48. PubMed ID: 20509659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.
    Carroll FI; Muresan AZ; Blough BE; Navarro HA; Mascarella SW; Eaton JB; Huang X; Damaj MI; Lukas RJ
    J Med Chem; 2011 Mar; 54(5):1441-8. PubMed ID: 21319801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues.
    Ondachi PW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
    ACS Chem Neurosci; 2016 Jul; 7(7):1004-12. PubMed ID: 27166021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK; Sumithran SP; Dwoskin LP
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Nicotinic Acetylcholine Receptor Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(substituted thiophenyl)deschloroepibatidine Analogues.
    Ondachi PW; Castro AH; Sherman B; Luetje CW; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
    ACS Chem Neurosci; 2017 Jan; 8(1):115-127. PubMed ID: 27726337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.
    Damaj MI; Carroll FI; Eaton JB; Navarro HA; Blough BE; Mirza S; Lukas RJ; Martin BR
    Mol Pharmacol; 2004 Sep; 66(3):675-82. PubMed ID: 15322260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
    Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
    ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.
    Carroll FI; Blough BE; Abraham P; Mills AC; Holleman JA; Wolckenhauer SA; Decker AM; Landavazo A; McElroy KT; Navarro HA; Gatch MB; Forster MJ
    J Med Chem; 2009 Nov; 52(21):6768-81. PubMed ID: 19821577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depression.
    Kozikowski AP; Eaton JB; Bajjuri KM; Chellappan SK; Chen Y; Karadi S; He R; Caldarone B; Manzano M; Yuen PW; Lukas RJ
    ChemMedChem; 2009 Aug; 4(8):1279-91. PubMed ID: 19569163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
    Rollema H; Hurst RS
    Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of alcohol taking and seeking by antagonism at α4β2 and α3β4 nAChRs.
    Cippitelli A; Brunori G; Schoch J; Armishaw CJ; Wu J; Zaveri NT; Giulianotti MA; Welmaker GS; Toll L
    Psychopharmacology (Berl); 2018 Jun; 235(6):1745-1757. PubMed ID: 29572652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U18666A, a cholesterol-inhibition agent, modulates human neuronal nicotinic acetylcholine receptors heterologously expressed in SH-EP1 cell line.
    Zheng C; Wang MY; Liu Q; Wakui M; Whiteaker P; Lukas RJ; Wu J
    J Neurochem; 2009 Mar; 108(6):1526-38. PubMed ID: 19183258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a nicotinic acetylcholine receptor ligand.
    Rao TS; Adams PB; Correa LD; Santori EM; Sacaan AI; Reid RT; Suto CM; Vernier JM
    Brain Res; 2003 Aug; 981(1-2):85-98. PubMed ID: 12885429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AT-1001 Is a Partial Agonist with High Affinity and Selectivity at Human and Rat α3β4 Nicotinic Cholinergic Receptors.
    Tuan EW; Horti AG; Olson TT; Gao Y; Stockmeier CA; Al-Muhtasib N; Bowman Dalley C; Lewin AE; Wolfe BB; Sahibzada N; Xiao Y; Kellar KJ
    Mol Pharmacol; 2015 Oct; 88(4):640-9. PubMed ID: 26162864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology.
    Cippitelli A; Wu J; Gaiolini KA; Mercatelli D; Schoch J; Gorman M; Ramirez A; Ciccocioppo R; Khroyan TV; Yasuda D; Zaveri NT; Pascual C; Xie XS; Toll L
    Br J Pharmacol; 2015 Apr; 172(7):1834-45. PubMed ID: 25440006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3'-Fluoro substitution in the pyridine ring of epibatidine improves selectivity and efficacy for alpha4beta2 versus alpha3beta4 nAChRs.
    Abdrakhmanova GR; Carroll FI; Damaj MI; Martin BR
    Neuropharmacology; 2008 Dec; 55(8):1287-92. PubMed ID: 18775444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues. Novel nicotinic antagonist.
    Carroll FI; Ware R; Brieaddy LE; Navarro HA; Damaj MI; Martin BR
    J Med Chem; 2004 Aug; 47(18):4588-94. PubMed ID: 15317468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinic receptor subtypes in rat hippocampal slices are differentially sensitive to desensitization and early in vivo functional up-regulation by nicotine and to block by bupropion.
    Alkondon M; Albuquerque EX
    J Pharmacol Exp Ther; 2005 May; 313(2):740-50. PubMed ID: 15647329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.
    Hansen CP; Jensen AA; Christensen JK; Balle T; Liljefors T; Frølund B
    J Med Chem; 2008 Dec; 51(23):7380-95. PubMed ID: 18989912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.